An indirect treatment comparison shows that dupilumab and tezepelumab yield broadly similar clinical benefits in patients ...

PHOENIX – Patients who have nasal polyps appeared to get symptom relief when treated with omalizumab (Xolair) regardless of comorbid asthma, according to a post-hoc trial analysis. All patients taking ...

With a high recurrence rate following surgery to treat chronic sinusitis with nasal polyps, authors set out to investigate the effectiveness and safety of endoscopic sinus surgery (ESS) in a pediatric ...

The nose is the subject of many sayings. A measurement could be on the nose or an object right under your nose. You may be reminded to keep your nose clean and out of another’s affairs. While often ...

Nasal polyp development, treatment, and recurrence were topics up for discussion in this year’s most popular nasal polyps–related content. Nasal polyp development, treatment, and recurrence, as well ...

Findings showed treatment with tezepelumab significantly reduced the size of nasal polyps and nasal congestion compared with placebo. The Food and Drug Administration (FDA) has approved Tezspire ® ...

Please provide your email address to receive an email when new articles are posted on . Patients with nasal polyposis often experience chronic rhinosinusitis, a high symptom burden and poor quality of ...

For severe chronic rhinosinusitis with nasal polyps, the novel monoclonal antibody stapokibart reduced symptoms and polyp size atop treatment with a daily intranasal corticosteroid. The polyp size ...

1 Add-on maintenance in patients with inadequate response to nasal steroids. 2 Add-on maintenance of chronic rhinosinusitis with nasal polyps (CRSwNP) in patients with inadequate response to nasal ...

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

Please provide your email address to receive an email when new articles are posted on . GlaxoSmithKline announced that the FDA has approved Nucala as a treatment for adults who have chronic ...